Experimental metastasis is suppressed in MMP-9-deficient mice

Clinical and Experimental Metastasis

Volumn 17, Issue 2, 1999, Pages 177-181

  Itoh, Takeshi ^a   Tanioka, Masatoshi ^a   Matsuda, Hidetoshi ^a   Nishimoto, Hirofumi ^a   Yoshioka, Takayuki ^a   Suzuki, Ryuji ^a   Uchira, Masahiro ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Experimental tumor metastasis; Gelatinase; Knockout mice; Matrix metalloproteinase

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER RESISTANCE; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GENE TARGETING; KNOCKOUT MOUSE; MELANOMA B16; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEINASE INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION; TUMOR CELL LINE; TUMOR MODEL; ZYMOGRAPHY;

ANIMALS; COLLAGENASES; GELATIN; GELATINASES; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 0032789885     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006603723759     Document Type: Article

References (20)

1. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991; 5: 2145-2154.
2. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121-125.
3. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, Liotta LA. The activation of human type IV collagenase proenzyme. J Biol Chem. 1989; 264: 1353-1356.
4. Docherty AJP, Lyons A, Smith BJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318: 66-69.
5. Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2). J Biol Chem 1989 264: 17374-17378.
6. Liotta LA, Tryggvason K, Garbisa S et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-68.
7. Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW, Muschel RJ. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion & Metastasis 1995; 14: 246-258.
8. Stetler-Stevenson WG. Progelatinase A activation during tumor cell invasion. Invasion & Metastasis 1995; 14: 259-268.
9. Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis. Cancer Res 1988; 58: 2209-2216.
10. Nielsen BS, Timshel S, Kjeldsen L et al. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996; 65: 57-62.
11. Segain JP, Harb J, Grégoire M, Meflah K, Menanteau J. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. Cancer Res 1996; 56: 5506-5512.
12. Himelstein BP, Canete-Soler R, Bernhard EJ, Muschel RJ. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci 1994; 107: 477-486.
13. Itoh T, Ikeda T, Gomi H et al. Unaltered secretion of β-amyloid precursor protein in gelatinase A (Matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997; 272: 22389-22392.
14. Itoh T, Tanioka M, Yoshida H et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998; 58: 1048-1051.
15. Yagi T, Ikawa Y, Yoshida K, et al. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc Natl Acad Sci USA 1990; 87: 9918-9922.
16. Gomi H, Yokoyama T, Fujimoto K et al. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 1995; 14: 29-41.
17. Hart IR. The selection and characterization of an invasive variant of the B16 melanoma. Am J Path 1979; 97: 587-600.
18. Uehira M, Matsuda H, Nakamura A, Nishimoto H. Immunologic abnormalities exhibited in IL-7 transgenic mice with dermatitis. J Invest Dermatol 1998; 110: 740-745.
19. Raz A, McLellan WL, Hart IR et al. Cell surface properties of B16 melanoma variants with differing metastatic potential. Cancer Res 1980; 40: 1645-1651.
20. Vu TH, Shipley JM, Bergers G et al. MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93: 411-422.